<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02556125</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201500402</org_study_id>
    <nct_id>NCT02556125</nct_id>
  </id_info>
  <brief_title>Diaphragm Pacing After Spinal Cord Injury</brief_title>
  <official_title>Intramuscular Pacing to Enhance Voluntary Diaphragm Activation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brooks Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Craig H. Neilsen Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory dysfunction is the leading cause of death in individuals with spinal cord
      injuries (SCIs). Nearly one quarter of all SCI cases involve injury to the upper spinal cord
      segments which impairs neural activation of the diaphragm muscle and compromises breathing.
      Although mechanical ventilation can be life-saving after cervical SCI (C-SCI), it also
      triggers rapid and profound diaphragm muscle atrophy, thereby complicating (or even
      preventing) ventilator weaning. Intramuscular diaphragm stimulation, or diaphragm pacing, was
      developed to replace long-term ventilator support, and is now used acutely post C-SCI (&lt;4
      months following injury) to promote ventilator weaning. The impact of diaphragm pacing on
      respiratory function and diaphragm muscle activation has not been formally evaluated. This is
      an essential step in determining the efficacy of intramuscular diaphragm stimulation and its
      effects on respiratory function after SCI. Accordingly, this research study will evaluate the
      effects of intramuscular diaphragm stimulation and test the hypothesis that diaphragm pacing
      enhances neuromuscular diaphragm activation and respiratory function in adults with cervical
      SCIs. The investigators will test the hypothesis by evaluating the effects of diaphragm
      pacing on neuromuscular activation of the diaphragm by directly recording electromyogram
      (EMG) activity from the intramuscular pacing electrodes. Recording from these
      surgically-implanted electrodes allows direct comparisons of EMG activity across time,
      minimizing methodological limitations inherent with surface or percutaneous EMG recordings.
      This approach, in association with respiratory assessments, will be used to investigate the
      impact of diaphragm pacing in adults with intramuscular diaphragm pacing electrodes following
      acute, traumatic C-SCIs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subject recruitment. Patients with acute, traumatic C-SCIs, scheduled to receive
      intramuscular diaphragm pacing OR who have recently received a diaphragm pacer (within past
      5-days) will be recruited from two Level-1 trauma hospitals serving North Florida - UF Health
      Shands Hospitals in Gainesville and Jacksonville, Florida.

      Enrollment. Patients with acute, traumatic C-SCIs (AIS A-C, affecting C1-C6 segments) who are
      scheduled to undergo or who have recently received implantation of diaphragm pacing
      electrodes (within recent 5-days) will be identified by the investigators.

      After obtaining informed consent for participation in the study, members of the study team
      will review the participant's medical records to obtain study-related data and verify that
      the participant meets the study criteria. Clinical tests of sensory and motor function also
      may be conducted to verify the participant's SCI classification and extent of SCI. The tests
      of sensory and motor function are part of the American Spinal Injury Association (ASIA)
      Impairment Scale and the International Standards for Neurological Classification of Spinal
      Cord Injury. These clinical assessments are part of standard clinical care and include tests
      of sensation (dermatomes) and muscle strength via manual muscle testing (myotomes). These
      tests are done to clinically determine which segmental levels of the spinal cord demonstrate
      normal or impaired function. These tests also aid in determining if the SCI is clinically
      complete or incomplete. Determination of complete versus incomplete is based on the sensory
      and motor function in the lowest sacral segments which control sensation and motor function
      at the anal sphincter. Respiratory function will be assessed by measurement of maximal
      expiratory pressures and standard spirometry (tidal breathing, maximal voluntary ventilation
      and flow-volume curves).

      Following enrollment and implantation of diaphragm pacing electrodes, individuals will be
      assessed at regular intervals. Assessments will include: a.) clinical ASIA neurologic
      examination of sensory and motor function (as described above) b.) recording of intramuscular
      diaphragm EMGs c.) measurement of diaphragm muscle strength via standard clinical assessment
      of maximal inspiratory pressures and d.) standard clinical measures of respiratory function.

      Up to 5 assessments will be conducted in the acute hospital setting; up to 5 assessments
      during inpatient rehabilitation (Brooks Rehabilitation); up to 4 assessments will be
      conducted after discharge to the home setting.

      ASSESSMENT OVERVIEW: The examination will allow investigators to characterize longitudinal
      changes in segmental sensory and motor function. Diaphragm electromyogram (EMG) will be
      recorded from the intramuscular diaphragm pacing electrodes and respiratory function will be
      assessed during non-stimulated respiration (diaphragm pacing unit turned off). Diaphragm EMGs
      will be recorded from the intramuscular pacing electrodes with a custom connector that
      attaches to the external pacing electrode wires and interfaces with an EMG acquisition
      system. Concurrent with EMG recordings, each assessment will include tests of maximal
      inspiratory pressures to assess diaphragm muscle strength.

      Assessment of the neuromuscular activation of the diaphragm will be performed. Neuromuscular
      activation of the diaphragm will be assessed by recording diaphragm EMGs from the
      surgically-implanted intramuscular stimulating electrodes. This approach will allow for
      comparisons of EMG recordings across time and reduces the methodological limitations
      associated with surface or percutaneous EMG approaches. EMGs will be recorded during
      non-stimulated respiration (diaphragm pacer turned off) and simultaneously with assessments
      of respiratory function. These assessments may include maximal inspiratory pressures; sniff
      nasal inspiratory pressure, maximal expiratory pressure, assessments of resting tidal
      breathing, inspiration to total lung capacity, maximal voluntary ventilation and measurement
      of flow volumes using standard spirometry.

      During the assessments, photographs and/or video recordings may be obtained. These recordings
      will be done with the participant's knowledge and consent for the type of recording being
      obtained. Photographs and video recordings will be used to communicate study procedures with
      the study team and to monitor the assessment process. Video and photographic data will be
      used to assess how individuals with SCIs perform and respond to the testing and to
      communicate the study procedures. Video and photographic information will be used in a manner
      based on the level of consent obtained from each participant.

      Primary outcomes to characterize neuromuscular activation of the diaphragm and assess changes
      in diaphragm activation associated with intramuscular diaphragm stimulation will include:
      amplitude and timing characteristics (raw, filtered EMGs and normalized); neural respiratory
      drive to evaluate diaphragm muscle activation during tidal breathing relative to activation
      capacity during maximal inspiratory maneuvers; and time-frequency characteristics of the
      diaphragm EMGs (wavelet analysis).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Electromyogram (EMG) will be used to assess the neuromuscular activation of the diaphragm</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Neuromuscular activation of the diaphragm will be assessed by recording diaphragm EMGs from the surgically-implanted intramuscular stimulating electrodes. This approach will allow for comparisons of EMG recordings across time. EMGs will be recorded during non-stimulated respiration (diaphragm pacer turned off) and simultaneously with assessments of respiratory function. A Friedman's ANOVA will be used to test for differences in the EMG outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal inspiratory pressure will be used to assess diaphragm strength</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Respiratory function will be assessed using standard clinical approaches to measure inspiratory and expiratory pressures and volumes as well as standard spirometry. A Friedman's ANOVA will be used to test for differences in the respiratory outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sniff nasal inspiratory pressure may be used to assess diaphragm strength</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Respiratory function will be assessed using standard clinical approaches to measure inspiratory and expiratory pressures and volumes as well as standard spirometry. A Friedman's ANOVA will be used to test for differences in the respiratory outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal expiratory pressure will be used to assess respiratory function</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Respiratory function will be assessed using standard clinical approaches to measure inspiratory and expiratory pressures and volumes as well as standard spirometry. A Friedman's ANOVA will be used to test for differences in the respiratory outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spirometry and flow volume curves/loops will be used to assess respiratory function at rest</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Respiratory function will be assessed using standard clinical approaches to measure inspiratory and expiratory pressures and volumes as well as standard spirometry. A Friedman's ANOVA will be used to test for differences in the respiratory outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spirometry and forced flow volume curves/loops will be used to assess respiratory function at maximal effort</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Respiratory function will be assessed using standard clinical approaches to measure inspiratory and expiratory pressures and volumes as well as standard spirometry. A Friedman's ANOVA will be used to test for differences in the respiratory outcomes across the multiple (4 or more) time points. Post-hoc comparisons will be conducted using a Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Spinal Cord Injury (ASIA) Impairment Scale</measure>
    <time_frame>Change in baseline to months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12</time_frame>
    <description>Standardized clinical assessment of sensation and strength based on levels of the spinal cord to classify the severity of injury. The test is clinician-administered; clinical examination conducted to test whether sensation is 0-absent; 1-impaired or 2-normal. The lower score the worse the paralysis and the higher the score will indicate the lesser of the paralysis.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Injuries, Spinal Cord</condition>
  <arm_group>
    <arm_group_label>Cervical SCI</arm_group_label>
    <description>Participants with acute, traumatic cervical spinal cord injuries (C-SCIs), classified according to the American Spinal Injury Association (ASIA) Impairment Scale (AIS) as A-C (complete SCI (A); motor complete SCI (B); motor incomplete with minimal motor function (C)), affecting C1-C6 spinal cord segments, and who have been scheduled to undergo implantation of a diaphragm pacer, or who have recently received (in past 5-days) implantation of intramuscular diaphragm pacing electrodes due to severe respiratory impairments and dependence on mechanical ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diaphragm pacing</intervention_name>
    <description>Intramuscular diaphragm implantation is achieved by a laparoscopic approach whereby phrenic motor points on the diaphragm are mapped to optimize electrode placement. The electrodes are threaded into the diaphragm muscle and wire leads are externalized and attached to a stimulation controller.</description>
    <arm_group_label>Cervical SCI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Forty adults will be recruited from an acute care hospital setting
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute, traumatic cervical spinal cord injuries (C-SCIs), classified according to the
             American Spinal Injury Association (ASIA) Impairment Scale (AIS) as A-C (complete SCI
             (A); motor complete SCI (B); motor incomplete with minimal motor function (C)),
             affecting C1-C6 spinal cord segments

          -  Scheduled to undergo implantation of a diaphragm pacer, or who have recently received
             (in past 5-days) implantation of intramuscular diaphragm pacing electrodes due to
             severe respiratory impairments and dependence on mechanical ventilation.

        Exclusion Criteria:

          -  Progressive neuromuscular diseases such as multiple sclerosis and myasthenia gravis

          -  History of neurologic injuries such as stroke or prior SCI

          -  Chest wall injuries or deformities likely to influence breathing

          -  Pulmonary infection

          -  Pregnancy

          -  Cognitive impairments limiting study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emily J Fox, PT, DPT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida; Brooks Rehabilitation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily J Fox, PT, DPT, PhD</last_name>
    <phone>352-273-6117</phone>
    <email>ejfox@phhp.ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily J Fox, PT, DPT, PhD</last_name>
      <phone>352-273-6117</phone>
      <email>ejfox@phhp.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brooks Rehabilitation</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Posluszny JA Jr, Onders R, Kerwin AJ, Weinstein MS, Stein DM, Knight J, Lottenberg L, Cheatham ML, Khansarinia S, Dayal S, Byers PM, Diebel L. Multicenter review of diaphragm pacing in spinal cord injury: successful not only in weaning from ventilators but also in bridging to independent respiration. J Trauma Acute Care Surg. 2014 Feb;76(2):303-9; discussion 309-10. doi: 10.1097/TA.0000000000000112.</citation>
    <PMID>24458038</PMID>
  </reference>
  <reference>
    <citation>Onders RP, Elmo M, Kaplan C, Katirji B, Schilz R. Extended use of diaphragm pacing in patients with unilateral or bilateral diaphragm dysfunction: a new therapeutic option. Surgery. 2014 Oct;156(4):776-84. doi: 10.1016/j.surg.2014.07.021.</citation>
    <PMID>25239317</PMID>
  </reference>
  <reference>
    <citation>Romero FJ, Gambarrutta C, Garcia-Forcada A, Mar√≠n MA, Diaz de la Lastra E, Paz F, Fernandez-Dorado MT, Mazaira J. Long-term evaluation of phrenic nerve pacing for respiratory failure due to high cervical spinal cord injury. Spinal Cord. 2012 Dec;50(12):895-8. doi: 10.1038/sc.2012.74. Epub 2012 Jul 10.</citation>
    <PMID>22777487</PMID>
  </reference>
  <reference>
    <citation>Hirschfeld S, Exner G, Luukkaala T, Baer GA. Mechanical ventilation or phrenic nerve stimulation for treatment of spinal cord injury-induced respiratory insufficiency. Spinal Cord. 2008 Nov;46(11):738-42. doi: 10.1038/sc.2008.43. Epub 2008 May 13.</citation>
    <PMID>18475279</PMID>
  </reference>
  <reference>
    <citation>Onders RP, Khansarinia S, Weiser T, Chin C, Hungness E, Soper N, Dehoyos A, Cole T, Ducko C. Multicenter analysis of diaphragm pacing in tetraplegics with cardiac pacemakers: positive implications for ventilator weaning in intensive care units. Surgery. 2010 Oct;148(4):893-7; discussion 897-8. doi: 10.1016/j.surg.2010.07.008. Epub 2010 Aug 24.</citation>
    <PMID>20797750</PMID>
  </reference>
  <reference>
    <citation>DiMarco AF, Onders RP, Kowalski KE, Miller ME, Ferek S, Mortimer JT. Phrenic nerve pacing in a tetraplegic patient via intramuscular diaphragm electrodes. Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1604-6.</citation>
    <PMID>12471076</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2015</study_first_submitted>
  <study_first_submitted_qc>September 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2015</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SCI</keyword>
  <keyword>Respiratory impairment</keyword>
  <keyword>Diaphragm pacing</keyword>
  <keyword>Diaphragm stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Spinal Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

